Clinical outcomes of stereotactic magnetic resonance image‐guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis
Stephanie Yoon(University of California, Los Angeles), Percy Lee(University of California, Los Angeles), Elaine Luterstein(University of California San Diego), Minsong Cao(Ronald Reagan UCLA Medical Center), Nzhde Agazaryan(University of California, Los Angeles), Michael L. Steinberg(University of California, Los Angeles), Ann C. Raldow(University of California, Los Angeles), Daniel A. Low(University of California, Los Angeles), Fang‐I Chu(University of California, Los Angeles), James Lamb(University of California, Los Angeles)
Cited by 42
Related Papers
Tolerance limits and methodologies for<scp>IMRT</scp>measurement‐based verification<scp>QA</scp>:<i>Recommendations of<scp>AAPM</scp>Task Group No. 218</i>
|Medical Physics|2018|1k
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology
|International Journal of Radiation Oncology*Biology*Physics|2020|314
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
|Practical Radiation Oncology|2021|261
The transformation of radiation oncology using real-time magnetic resonance guidance: A review
|European Journal of Cancer|2019|182
A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy
|Advances in Radiation Oncology|2018|161